Clomiphene Citrate a First Step to Improve Idiopathic Male Infertility: A Retrospective Analysis
Table 1
Patient characteristics at baseline.
Characteristics
Total 52 patients
Age, mean ± SD (range), years
35.4 ± 6.6 (23–59)
(n = 52)
Overweight (BMI > 25 kg/m2), n (%)
25 (63)
(n = 40)
BMI, median (IQR)
26.9 (24.1–29.6)
(n = 40)
Current smoker, n (%)
7 (14)
(n = 50)
Testis volume, mL
Left testis, median (range)
13.5 (3.0–23.0)
(n = 44)
Right testis, median (range)
14.4 (23.0–30.0)
(n = 46)
Medical history, n (%)
(n = 52)
Orchiectomy
6 (12)
Orchidopexy
8 (15)
Diabetes mellitus
1 (2)
Testicular tumor
5 (10)
Usage of TTh in past >1 year
6 (12)
Elevated FSH
23 (46)
Hypogonadal hypogonadism
48 (92)
Dosage of CC therapy at start, n (%)
(n = 52)
25 mg/2 day
46 (88)
25 mg/day
1 (2)
50 mg/2 day
4 (8)
50 mg/day
2 (4)
n, number of patients; BMI, body mass index; FU, follow-up; SD, standard deviation; IQR, interquartile range; TTh, testosterone replacement therapy. Elevated follicle stimulating hormone > 10.3 IU/L. Hypogonadal hypogonadism = total testosterone < 12.1 nmol/L.
